Seasonal Influenza

Influenza is a serious illness that can affect even fit and healthy people, reducing workforce productivity and increasing absenteeism.

Workplace immunisation against influenza has been demonstrated to produce real cost savings over time, with independent studies showing a typical return on investment of around $2.50 for each dollar invested.

Offering immunisation to staff in the workplace eliminates the cost and inconvenience associated with visiting a medical clinic and buying the vaccine from a pharmacy. This translates to higher uptake, and a greater overall benefit to your organisation.

The ProVax difference
ProVax’s immunisation programs are delivered exclusively by Division 1 Registered Nurses. All ProVax Nurse Immunisers hold additional immunisation accreditation where required by State and Territory legislation.

We employ Nurse Immunisers in all capital cities and many regional centres, giving us an extensive geographic reach. Our proven experience in managing complex, multi-site programs has made us the immunisation provider of choice for some of Australia’s largest companies.

With ProVax’s online booking system, long queues outside the immunisation room are a thing of the past. In 2008, staff vaccinated by ProVax reported an average waiting time of just three minutes.

And best of all, we’re proud to report that 75% of vaccinated staff told us that their vaccination was completely painless!

To find out how we can help protect your workforce from influenza, contact our office on 1300 662 328.

2009 Seasonal flu vaccine composition
The Australian Influenza Vaccine Committee has recommended that vaccines to be used in the 2009 season (southern hemisphere winter) contain the following:

— A (H1N1): an A/Brisbane/59/2007 (H1N1)-like strain;
— A (H3N2): an A/Brisbane/10/2007 (H3N2)-like strain;
— B: a B/Florida/4/2006-like strain.

Details can be found on the WHO web site.